Get started
U-NEURON BIOMEDICAL INCU-NEURON BIOMEDICAL INCU-NEURON BIOMEDICAL INC

U-NEURON BIOMEDICAL INC

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

6973 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

U-Neuron Biomedical, Inc. engages in the research and development of stem cell storage and separation technology, and treatment application technology. It focuses in the study of Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. The company was founded on September 4, 2015 and is headquartered in New Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6973 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company